World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
21957
World Ranking
16740
National Ranking
8396

Qizhi Yao publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Qizhi Yao sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 353 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Qizhi Yao D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Qizhi Yao sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Qizhi Yao is a researcher affiliated with Baylor College of Medicine in the United States. Their work primarily spans the fields of medicine and biochemistry, genetics, and molecular biology, with a substantial focus on molecular biology, oncology, cancer research, immunology, and surgery.

The main topics covered in their research include pancreatic and hepatic oncology research, cancer genomics and diagnostics, epigenetics and DNA methylation, pancreatitis pathology and treatment, CAR-T cell therapy research, microRNA in disease regulation, and endoplasmic reticulum stress and disease.

Qizhi Yao has published research in several notable venues, frequently contributing to Cancer Research, Vaccines, University Chemistry, Goldschmidt Abstracts, and the Journal of Clinical Oncology.

Among their recent papers are:

  • "Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors," 2023, Science
  • "A Transcriptome-Wide Association Study Identifies Candidate Susceptibility Genes for Pancreatic Cancer Risk," 2020, Cancer Research
  • "Microbiome changes associated with acute and chronic pancreatitis: A systematic review," 2020, Pancreatology
  • "A subset of cytotoxic effector memory T cells enhances CAR T cell efficacy in a model of pancreatic ductal adenocarcinoma," 2021, Science Translational Medicine
  • "Two Antibody-Guided Lactic-co-Glycolic Acid-Polyethylenimine (LGA-PEI) Nanoparticle Delivery Systems for Therapeutic Nucleic Acids," 2021, Pharmaceuticals

The scientist regularly collaborates with several coauthors, including Dongliang Liu, Changyi Chen, Zhengdong Liang, Lisa Brubaker, and Jianming Lü, reflecting ongoing partnerships in various research endeavors.

Best Publications

  • Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems.

    Jian-Ming Lü;Peter H. Lin;Peter H. Lin;Qizhi Yao;Qizhi Yao;Changyi Chen;Changyi Chen

  • Current advances in research and clinical applications of PLGA-based nanotechnology

    Jian-Ming Lü;Xinwen Wang;Christian Marin-Muller;Hao Wang

  • Ginseng Compounds: An Update on Their Molecular Mechanisms and Medical Applications

    Jian-Ming Lu;Qizhi Yao;Changyi Chen

  • Resistin: functional roles and therapeutic considerations for cardiovascular disease

    S Jamaluddin;Sarah M Weakley;Qizhi Yao;Changyi Chen

  • Profiling of 95 MicroRNAs in Pancreatic Cancer Cell Lines and Surgical Specimens by Real-Time PCR Analysis

    Yuqing Zhang;Min Li;Hao Wang;William E. Fisher

  • Reverse cholesterol transport and cholesterol efflux in atherosclerosis

    R Ohashi;H Mu;X Wang;Q Yao

  • Shear Stress Induces Endothelial Differentiation From a Murine Embryonic Mesenchymal Progenitor Cell Line

    Hao Wang;Gordon M. Riha;Shaoyu Yan;Min Li

  • Long-term reversal of diabetes by the injection of immunoprotected islets

    P Soon-Shiong;E Feldman;R Nelson;R Heintz

  • MicroRNAs: Control and loss of control in human physiology and disease

    Min Li;Christian Marin-Muller;Uddalak Bharadwaj;Kwong Hon Chow

  • Adipokine resistin promotes in vitro angiogenesis of human endothelial cells

    Hong Mu;Ryuji Ohashi;Shaoyu Yan;Hong Chai

  • Development of small-diameter vascular grafts.

    Xinwen Wang;Peter Lin;Qizhi Yao;Changyi Chen

  • Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview

    Changyi Chen;Jian-Ming Lü;Qizhi Yao

  • Overcoming drug resistance in pancreatic cancer

    Jiang Long;Yuqing Zhang;Xianjun Yu;Jingxuan Yang

  • Aberrant expression of zinc transporter zip4 (slc39a4) significantly contributes to human pancreatic cancer pathogenesis and progression

    Qizhi Yao;Min Li;Changyi Chen

  • MicroRNA-196: critical roles and clinical applications in development and cancer.

    Changyi J. Chen;Yuqing Zhang;Lidong Zhang;Sarah M. Weakley

  • Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells

    Changyi Chen;Changyi Chen;Jun Jiang;Jian-Ming Lü;Hong Chai

  • Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease.

    Panagiotis Kougias;Hong Chai;Peter H. Lin;Qizhi Yao

  • Ginkgo biloba extract kaempferol inhibits cell proliferation and induces apoptosis in pancreatic cancer cells.

    Yuqing Zhang;Aaron Y. Chen;Min Li;Changyi Chen

  • Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway

    Rafael A Cubas;Sheng Zhang;Min Li;Changyi Chen

  • Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147

    Min Li;Qihui Zhai;Uddalak Bharadwaj;Hao Wang

Frequent Co-Authors

Changyi Chen
Changyi Chen Baylor College of Medicine
Alan B. Lumsden
Alan B. Lumsden Houston Methodist
Richard W. Compans
Richard W. Compans Emory University
Sang-Moo Kang
Sang-Moo Kang Georgia State University
Craig D. Logsdon
Craig D. Logsdon The University of Texas MD Anderson Cancer Center
Xianjun Yu
Xianjun Yu Fudan University
Robert Cousins
Robert Cousins University of California, Los Angeles
Celia C. LaBranche
Celia C. LaBranche Duke University
Eric R. Gamazon
Eric R. Gamazon Vanderbilt University Medical Center
Richard A. Gibbs
Richard A. Gibbs Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical careers in the USA opens doors to many related healthcare degrees and flexible online pathways. Many professionals opt for online programs to fit education around work and family life, and these innovative options are rapidly expanding.

If you are a working adult interested in healthcare administration, choosing a program that balances quality and flexibility is essential. Check out whats the best online mha program for working adults to find highly-ranked options accredited for career advancement.

Registered nurses looking to further their qualifications often prefer programs that skip on-site clinicals. For streamlined choices, explore rn to bsn online no clinicals, which highlights BSN degrees that eliminate lengthy clinical requirements.

For advanced practice or leadership roles, consider fast-track options like the fastest dnp program or the dnp program without clinical hours. These doctorates are tailored for convenience, allowing many to complete rigorous training in less time with minimal or no clinical hours.

Each of these online pathways helps make higher education accessible, streamlining entry and advancement within today’s competitive healthcare sector.

Best Scientists Citing Qizhi Yao

Trending Scientists

Recently Published Articles